These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8514849)

  • 21. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
    Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O
    J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin receptor function and glycogen synthase activity in human skeletal muscle. Physiology and pathophysiology.
    Bak JF
    Dan Med Bull; 1994 Apr; 41(2):179-92. PubMed ID: 8039433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
    Vaag A; Alford F; Beck-Nielsen H
    Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin.
    Damsbo P; Hermann LS; Vaag A; Hother-Nielsen O; Beck-Nielsen H
    Diabetes Care; 1998 Sep; 21(9):1489-94. PubMed ID: 9727896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis.
    Iozzo P; Pratipanawatr T; Pijl H; Vogt C; Kumar V; Pipek R; Matsuda M; Mandarino LJ; Cusi KJ; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2001 May; 280(5):E712-9. PubMed ID: 11287353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM.
    Wright KS; Beck-Nielsen H; Kolterman OG; Mandarino LJ
    Diabetes; 1988 Apr; 37(4):436-40. PubMed ID: 2837418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of acute (60 minute) insulin stimulation upon human skeletal muscle glycogen synthase and protein phosphatase-1 in non-insulin-dependent diabetic patients and control subjects.
    Barriocanal LA; Borthwick AC; Stewart M; Wells A; Hurel SJ; Yeaman SJ; Taylor R
    Diabet Med; 1995 Dec; 12(12):1110-5. PubMed ID: 8750222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM.
    Yki-Järvinen H; Daniels MC; Virkamäki A; Mäkimattila S; DeFronzo RA; McClain D
    Diabetes; 1996 Mar; 45(3):302-7. PubMed ID: 8593934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe insulin-resistant diabetes mellitus in patients with congenital muscle fiber type disproportion myopathy.
    Vestergaard H; Klein HH; Hansen T; Müller J; Skovby F; Bjørbaek C; Røder ME; Pedersen O
    J Clin Invest; 1995 Apr; 95(4):1925-32. PubMed ID: 7706500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of insulin resistance in human skeletal muscle cells by downregulation of glycogen synthase protein expression.
    Park KS; Ciaraldi TP; Carter L; Mudaliar S; Nikoulina SE; Webster NJ; Henry RR
    Metabolism; 2000 Aug; 49(8):962-8. PubMed ID: 10954011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo insulin regulation of skeletal muscle glycogen synthase in calorie-restricted and in ad libitum-fed rhesus monkeys.
    Ortmeyer HK
    J Nutr; 2001 Mar; 131(3):907S-912S. PubMed ID: 11238784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.
    Simoneau JA; Kelley DE
    J Appl Physiol (1985); 1997 Jul; 83(1):166-71. PubMed ID: 9216960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular defects in glucose metabolism in obese patients with NIDDM.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus.
    Damsbo P; Vaag A; Hother-Nielsen O; Beck-Nielsen H
    Diabetologia; 1991 Apr; 34(4):239-45. PubMed ID: 1906024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle of patients with type 2 diabetes.
    Vind BF; Birk JB; Vienberg SG; Andersen B; Beck-Nielsen H; Wojtaszewski JF; Højlund K
    Diabetologia; 2012 May; 55(5):1435-45. PubMed ID: 22322917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients.
    Bjørbaek C; Vik TA; Echwald SM; Yang PY; Vestergaard H; Wang JP; Webb GC; Richmond K; Hansen T; Erikson RL
    Diabetes; 1995 Jan; 44(1):90-7. PubMed ID: 7813820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.